Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list.

NanoPortal™ technology successfully delivers semaglutide, the active ingredient in Ozempic®/Wegovy®, in a preclinical study ...

Vivani Medical, Inc. (VANI), on Wednesday, announced promising preclinical data for its semaglutide implant in development ...

Stephanie Anderson Witmer is a freelance journalist based in Pennsylvania. Her work has been published in other top magazines and digital publications, including Prevention, Good Housekeeping ...

Is the era of sourcing cheaper weight loss drugs from the internet over? High demand for GLP-1 agonists — prescription drugs ...

weight change from baseline for NPM-139 (semaglutide) corrected to control (sham implant). Values are mean ± SE. Weight difference versus control group in healthy Sprague-Dawley Rats.

NPM-139 treatment resulted in nearly 20% placebo-adjusted weight loss from a single administration ... study in healthy rats, a single administration of the semaglutide implant NPM-139 resulted ...

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...